First Results Reported for Prostate Cancer Targeted Brachytherapy ...
CivaTech Oncology Inc. has developed a new U.S. Food and Drug Administration (FDA)-cleared radiation source. The CivaString source features 103Pd (palladium) along the full length of the device, which is contained using low-Z polymers.